Matches in Wikidata for { <http://www.wikidata.org/entity/Q70987279> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q70987279 description "article scientifique publié en 1995" @default.
- Q70987279 description "artículu científicu espublizáu n'avientu de 1995" @default.
- Q70987279 description "im Dezember 1995 veröffentlichter wissenschaftlicher Artikel" @default.
- Q70987279 description "scientific article published on 01 December 1995" @default.
- Q70987279 description "wetenschappelijk artikel" @default.
- Q70987279 description "наукова стаття, опублікована в грудні 1995" @default.
- Q70987279 name "Does the enhancement of cholinergic neurotransmission influence brain glucose kinetics and clinical symptomatology in progressive supranuclear palsy?" @default.
- Q70987279 name "Does the enhancement of cholinergic neurotransmission influence brain glucose kinetics and clinical symptomatology in progressive supranuclear palsy?" @default.
- Q70987279 type Item @default.
- Q70987279 label "Does the enhancement of cholinergic neurotransmission influence brain glucose kinetics and clinical symptomatology in progressive supranuclear palsy?" @default.
- Q70987279 label "Does the enhancement of cholinergic neurotransmission influence brain glucose kinetics and clinical symptomatology in progressive supranuclear palsy?" @default.
- Q70987279 prefLabel "Does the enhancement of cholinergic neurotransmission influence brain glucose kinetics and clinical symptomatology in progressive supranuclear palsy?" @default.
- Q70987279 prefLabel "Does the enhancement of cholinergic neurotransmission influence brain glucose kinetics and clinical symptomatology in progressive supranuclear palsy?" @default.
- Q70987279 P1433 Q70987279-0FDA8F87-9D71-4A71-A746-6E86AF04AA89 @default.
- Q70987279 P1476 Q70987279-1BB1087B-CEF3-4497-94AC-714F0389FE9B @default.
- Q70987279 P2093 Q70987279-0939E2A7-5188-4EEC-BB1E-C5BA3ED19717 @default.
- Q70987279 P2093 Q70987279-4C42EA32-E2E0-4B12-8035-A227BFFE086D @default.
- Q70987279 P2093 Q70987279-855A1C4A-2BE5-48FD-AE0C-796FF2213207 @default.
- Q70987279 P2093 Q70987279-933A9FB9-1771-423A-A00D-89D12FA84B20 @default.
- Q70987279 P2093 Q70987279-A0551EA9-845E-40BA-A5F0-320B29BB1704 @default.
- Q70987279 P2093 Q70987279-E38BAF43-B7A8-4334-8626-28E05E25C61D @default.
- Q70987279 P2093 Q70987279-FCD5F36A-C5CB-451B-8694-22BA37E43C9F @default.
- Q70987279 P304 Q70987279-C2CEEBFA-BD93-4F39-927B-426E87F29D54 @default.
- Q70987279 P31 Q70987279-81F5A429-28B9-4A72-8075-3FEB32A4CC75 @default.
- Q70987279 P356 Q70987279-FBB4C523-1AE7-48AA-A1C8-C833BE7DC7AD @default.
- Q70987279 P478 Q70987279-20A55E81-0DB4-4F30-B7DF-07F279A92AFA @default.
- Q70987279 P50 Q70987279-12C160CC-9D75-41E5-963D-BB886EFBC5E9 @default.
- Q70987279 P577 Q70987279-7FCA3F31-1E4F-4479-B42D-FE41379B198D @default.
- Q70987279 P698 Q70987279-E9586325-EB6B-487D-B8FD-8BA85DD17039 @default.
- Q70987279 P356 118.6.1485 @default.
- Q70987279 P698 8595479 @default.
- Q70987279 P1433 Q897386 @default.
- Q70987279 P1476 "Does the enhancement of cholinergic neurotransmission influence brain glucose kinetics and clinical symptomatology in progressive supranuclear palsy?" @default.
- Q70987279 P2093 "B Mazoyer" @default.
- Q70987279 P2093 "B Pillon" @default.
- Q70987279 P2093 "C Malapani" @default.
- Q70987279 P2093 "P Mazetti" @default.
- Q70987279 P2093 "S Ben Ayed" @default.
- Q70987279 P2093 "S Rivaud" @default.
- Q70987279 P2093 "Y Agid" @default.
- Q70987279 P304 "1485-1495" @default.
- Q70987279 P31 Q13442814 @default.
- Q70987279 P356 "10.1093/BRAIN/118.6.1485" @default.
- Q70987279 P478 "118 ( Pt 6)" @default.
- Q70987279 P50 Q67209179 @default.
- Q70987279 P577 "1995-12-01T00:00:00Z" @default.
- Q70987279 P698 "8595479" @default.